Boivin D., James F. O., Wu A., Cho-Park P. F., Xiong H., Sun Z. S. (2003). Circadian clock genes oscillate in human peripheral blood mononuclear cells, Blood , 102 (12 ), 4143-5.

Boivin D., Santo J. B. (2003). Circadian rythm sleep disorders related to an abnormal escape of the sleep-wake cycle . Dans Billiard M. (Éd.) , Sleep: Physiology, Investigations, and Medicine (pp. 493-512). Kluwer-Academic Press.

Boksa P., Luheshi G. (2003). On the use of animal modeling to study maternal infection during pregnancy and prenatal cytokine exposure as risk factors for schizophrenia, Clin Neurosci Res , 3 (4-5 ), 339-346.

Brillet K., Kieffer B., Massotte D. (2003). Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening, BMC Pharmacol, 3, 14. En savoir plus.

Brown T., Topp J., Ross D. (2003). Rationales, obstacles and strategies for local outcome monitoring systems in substance abuse treatment settings, J Subst Abuse Treat , 24 (1 ), 31-42.

Bruce K.R., Koerner N. M., Steiger H., Young S. N. (2003). Laxative misuse and behavioral disinhibition in bulimia nervosa, Int J Eat Disord , 33 (1 ), 92-7.

Brunet A., St-Hilaire A., Jehel L., King S. (2003). Validation of a French version of the impact of event scale-revised, Can J Psychiatry , 48 (1 ), 56-61.

Castane A., Robledo P., Matifas A., Kieffer B., Maldonado R. (2003). Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice, Eur J Neurosci, 17(1), 155-9. En savoir plus.

Cermakian N., Boivin D. (2003). A molecular perspective of human circadian rhythm disorders, Brain Res Brain Res Rev , 42 (3 ), 204-20.

Cermakian N., Pando M. P., Doi M., Cardone L., Yujnovsky I., Morse D., Sassone-Corsi P. (2003). On the communication pathways between the central pacemaker and peripheral oscillators, Novartis Found Symp , 253 , 126-136; discussion 136-139.

Champagne D., Pearson D., Dea D., Rochford J., Poirier J. (2003). The cholesterol-lowering drug Probucol increases apolipoprotein e production in the hippocampus of aged rats: implications for Alzheimer's disease, Neuroscience , 121 (1 ), 99-110.

Chefer V. I., Kieffer B., Shippenberg T. S. (2003). Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice, Eur J Neurosci, 18(7), 1915-22. En savoir plus.

Decaillot F. M., Befort K., Filliol D., Yue S., Walker P., Kieffer B. (2003). Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation, Nat Struct Biol, 10(8), 629-36. En savoir plus.

Desautels A., Turecki G., Montplaisir J., Brisebois K., Desautels A. K., Adam B., Rouleau G. A. (2003). Analysis of CAG repeat expansions in restless legs syndrome, Sleep , 26 (8 ), 1055-7.

Desautels A., Turecki G., Montplaisir J., Rochefort D., Rouleau G. A. (2003). Mutational analysis of neurotensin in familial RLS, Mov Disord , 19 , 90-94.

Deschamps S., Woodside B., Walker C. (2003). Pups presence eliminates the stress hyporesponsiveness of early lactating females to a psychological stress representing a threat to the pups, J Neuroendocrinol , 15 (5 ), 486-97.

Dongier M. (2003). What treatment options exist for alcohol abuse?, J Psychiatry Neurosci , 28 (1 ), 80.

Dongier M., Brown T. (2003). Nursing research and alcohol problems: learning from recent history?, Can J Nurs Res , 35 (1 ), 13-22.

Dupre N., Verlaan D. J., Hand C. K., Laurent S. B., Turecki G., Davenport W. J., Acciarri N., Dichgans J., Ohkuma A., Siegel A. M., Rouleau G. A. (2003). Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation, Can J Neurol Sci , 30 (2 ), 122-8.

Fleck M. P., Chachamovich E., Trentini C. M. (2003). [WHOQOL-OLD Project: method and focus group results in Brazil], Rev Saude Publica, 37(6), 793-9. En savoir plus.